Read the full article here.
This content was originally published by Forbes Magazine. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Forbes Magazine
The study’s small size and other weaknesses mean it does not offer a lot of helpful information in determining the possible utility of hydroxychloroquine, according to experts who reviewed the study.